VBCG
MEDP icon

Valley Brook Capital Group’s Medpace MEDP Stock Holding History

Valley Brook Capital Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$16K – 289
2021
Q1 		$16K Hold
100
– – 0.01% 325
2020
Q4 		$13K Buy
+100
New +$12.6K 0.01% 310

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Valley Brook Capital Group's MEDP Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Medpace (MEDP) in Q2 2021, closing a stake of 100 shares — an estimated $16K sold.

Valley Brook Capital Group first reported a position in MEDP in Q4 2020 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 324 funds tracked by Wall St. Rank hold MEDP as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Medpace position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 100 Medpace shares in Q2 2021, an estimated $16K.
  • Valley Brook Capital Group first reported a position in Medpace in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Medpace position peaked at $16K in Q1 2021.
  • 324 funds tracked by Wall St. Rank held Medpace as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.